8-K

Company

Lyra Therapeutics, Inc.

Filed

December 28, 2023

Period of Report

December 21, 2023

Accession Number

0000950170-23-073432

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →